Roland B. Walter

19.5k total citations · 3 hit papers
365 papers, 11.0k citations indexed

About

Roland B. Walter is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Roland B. Walter has authored 365 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 242 papers in Hematology, 122 papers in Oncology and 109 papers in Molecular Biology. Recurrent topics in Roland B. Walter's work include Acute Myeloid Leukemia Research (217 papers), Acute Lymphoblastic Leukemia research (66 papers) and Hematopoietic Stem Cell Transplantation (57 papers). Roland B. Walter is often cited by papers focused on Acute Myeloid Leukemia Research (217 papers), Acute Lymphoblastic Leukemia research (66 papers) and Hematopoietic Stem Cell Transplantation (57 papers). Roland B. Walter collaborates with scholars based in United States, South Africa and Switzerland. Roland B. Walter's co-authors include Elihu H. Estey, Frederick R. Appelbaum, Irwin D. Bernstein, Megan Othus, Brent L. Wood, Farhad Ravandi, Sarah Buckley, John M. Pagel, Anna B. Halpern and George S. Laszlo and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Roland B. Walter

341 papers receiving 10.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia

2013 460 citations Harry P. Erba, Roland B. Walter et al. Blood profile →
Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study

2019 456 citations Andrew H. Wei, Stephen A. Strickland et al. Journal of Clinical Oncology profile →
Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia

2020 207 citations Roland B. Walter, Xuelin Huang et al. profile →

Peers

Countries citing papers authored by Roland B. Walter

Since Specialization

Citations

This map shows the geographic impact of Roland B. Walter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland B. Walter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland B. Walter more than expected).

Fields of papers citing papers by Roland B. Walter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland B. Walter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland B. Walter. The network helps show where Roland B. Walter may publish in the future.

Co-authorship network of co-authors of Roland B. Walter

This figure shows the co-authorship network connecting the top 25 collaborators of Roland B. Walter. A scholar is included among the top collaborators of Roland B. Walter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland B. Walter. Roland B. Walter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Protection of CD33-modified hematopoietic stem cell progeny from CD33-directed CAR T cells in rhesus macaques 2025 ·Blood Advances ·Nicholas Petty, Stefan Radtke, (unknown), (unknown), Olivier Humbert, (unknown), (unknown), George S. Laszlo, (unknown), (unknown), (unknown), Haiying Zhu, Keith R. Jerome, Cameron J. Turtle, Roland B. Walter, Hans‐Peter Kiem	0
2	Preclinical characterization of the anti-leukemia activity of the CD123 antibody-drug conjugate, pivekimab sunirine (IMGN632) 2025 ·Leukemia ·(unknown), George S. Laszlo, (unknown), (unknown), Patrick A. Zweidler‐McKay, Eduardo Rodríguez‐Arbolí, David Wu, (unknown), Junyang Li, (unknown), (unknown), Sribalaji Lakshmikanthan, Roland B. Walter	1
3	CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial 2024 ·Cancers ·Scott R. Solomon, Bayard L. Powell, (unknown), Catherine Lai, (unknown), Laura C. Michaelis, Laura F. Newell, David Sanford, (unknown), (unknown), (unknown), Stefan Faderl, Roland B. Walter	0
4	Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML 2024 ·American Journal of Hematology ·Corentin Orvain, (unknown), Megan Othus, Eduardo Rodríguez‐Arbolí, Filippo Milano, (unknown), Brenda M. Sandmaier, Bart L. Scott, Frederick R. Appelbaum, Roland B. Walter	4
5	Optimizing Siglec-8-Directed Immunotherapy for Eosinophilic and Mast Cell Disorders 2024 ·Cancers ·(unknown), (unknown), George S. Laszlo, (unknown), (unknown), Junyang Li, (unknown), (unknown), Peter B. Rupert, Roland K. Strong, Roland B. Walter	1
6	CD45-Directed Radioimmunotherapy with the Alpha-Emitter Astatine-211 As Conditioning for Autologous Hematopoietic Stem/Progenitor Cell Gene Therapy: Results from a Nonhuman Primate Model 2024 ·Blood ·Stefan Radtke, (unknown), George S. Laszlo, (unknown), (unknown), Nicholas Petty, Donald K. Hamlin, D. Scott Wilbur, Brenda M. Sandmaier, Hans‐Peter Kiem, Roland B. Walter	0
7	A phase 1b/2 study of pivekimab sunirine (PVEK, IMGN632) in combination with venetoclax/azacitidine for patients with newly diagnosed CD123-positive acute myeloid leukemia. 2024 ·Journal of Clinical Oncology ·Naval Daver, Pau Montesinos, Jessica K. Altman, Anjali S. Advani, Eunice S. Wang, Sylvain Garciaz, Giovanni Martinelli, Gail J. Roboz, Roland B. Walter, Kebede H. Begna, Monia Lunghi, Uwe Platzbecker, Paresh Vyas, Patrick W. Burke, Antonio Curti, Daniel J. DeAngelo, Lauris Gastaud, Christoph Schliemann, Benjamin Oshrine, David A. Sallman	1
8	Hematopoietic stem cell transplant for adults with mixed phenotypic acute leukemia. 2024 ·Journal of Clinical Oncology ·(unknown), Jacob Appelbaum, Kathryn Russell, (unknown), (unknown), Xueyan Chen, (unknown), Paul C. Hendrie, Anna B. Halpern, Raya Mawad, Ryan D. Cassaday, Roland B. Walter, Mary‐Elizabeth M. Percival, (unknown)	0
9	Poor post-induction outcomes in patients with acute myeloid leukemia previously treated with hypomethylating agents 2023 ·Leukemia & lymphoma ·(unknown), Megan Othus, (unknown), (unknown), Anna B. Halpern, Jacob Appelbaum, Paul C. Hendrie, Roland B. Walter, Elihu H. Estey, Mary‐Elizabeth M. Percival	1
10	Evaluating concordance in assessment of ECOG performance status in acute myeloid leukemia patients 2022 ·Leukemia ·(unknown), (unknown), Roland B. Walter, Mary‐Elizabeth M. Percival, Elihu H. Estey	1
11	Comparative analysis of infectious complications with outpatient vs. inpatient care for adults with high-risk myeloid neoplasm receiving intensive induction chemotherapy 2021 ·Leukemia & lymphoma ·Anna B. Halpern, Megan Othus, Nicholas P. Howard, Paul C. Hendrie, Mary‐Elizabeth M. Percival, (unknown), Verna Welch, Elihu H. Estey, Roland B. Walter	2
12	Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study breakdown → 2019 ·Journal of Clinical Oncology ·Andrew H. Wei, Stephen A. Strickland, Jing-Zhou Hou, Walter Fiedler, Tara L. Lin, Roland B. Walter, Anoop Enjeti, Ing Soo Tiong, Michael R. Savona, Sang‐Min Lee, Brenda Chyla, Relja Popovic, Ahmed Hamed Salem, Suresh Agarwal, Tu Xu, Kaffa Fakouhi, Rod Humerickhouse, (unknown), John Hayslip, Gail J. Roboz	456
13	Accrual Barriers and Detection of Early Toxicity Signal in Older Less-Fit Patients Treated with Azacitidine and Nivolumab for Newly Diagnosed Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) in the SWOG 1612 Platform Randomized Phase II/III Clinical Trial 2019 ·Blood ·Annette E. Hay, Sarit Assouline, Roland B. Walter, Richard F. Little, Anna Moseley, (unknown), Annie Im, James M. Foran, Jerald P. Radich, Min Fang, Megan Othus, Harry P. Erba, Laura C. Michaelis	7
14	Characterization of CD33/CD3 Tetravalent Bispecific Tandem Diabodies (TandAbs) for the Treatment of Acute Myeloid Leukemia 2016 ·Clinical Cancer Research ·Uwe Reusch, Kimberly H. Harrington, Chelsea J. Gudgeon, Ivica Fucek, Kristina Ellwanger, Michael Weichel, Stefan Knackmuss, Eugene A. Zhukovsky, Judith A. Fox, Lori Kunkel, Jeanmarie Guenot, Roland B. Walter	76
15	Multimerin-1 ( MMRN1 ) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group 2015 ·Clinical Cancer Research ·George S. Laszlo, Todd A. Alonzo, Chelsea J. Gudgeon, Kimberly H. Harrington, Robert B. Gerbing, Yi-Cheng Wang, Rhonda E. Ries, Susana C. Raimondi, Betsy Hirsch, Alan S. Gamis, Soheil Meshinchi, Roland B. Walter	20
16	Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease–Based Definition of Complete Remission? 2015 ·Journal of Clinical Oncology ·Daisuke Araki, Brent L. Wood, Megan Othus, Jerald P. Radich, Anna B. Halpern, Yi Zhou, Marco Mielcarek, Elihu H. Estey, Frederick R. Appelbaum, Roland B. Walter	258
17	Preclinical and Early Clinical Evaluation of the Oral AKT Inhibitor, MK-2206, for the Treatment of Acute Myelogenous Leukemia 2014 ·Clinical Cancer Research ·Marina Konopleva, Roland B. Walter, Stefan Faderl, Elias Jabbour, Zhihong Zeng, Gautam Borthakur, Xuelin Huang, Tapan M. Kadia, Peter P. Ruvolo, Jennie B. Feliu, Hongbo Lu, (unknown), Jan A. Burger, Michael Andreeff, Wenbin Liu, Keith Baggerly, Steven M. Kornblau, L. Austin Doyle, Elihu H. Estey, Hagop M. Kantarjian	70
18	Clinical Significance of CD33 Nonsynonymous Single-Nucleotide Polymorphisms in Pediatric Patients with Acute Myeloid Leukemia Treated with Gemtuzumab-Ozogamicin–Containing Chemotherapy 2013 ·Clinical Cancer Research ·(unknown), Todd A. Alonzo, Roland B. Walter, Robert B. Gerbing, Amit Mitra, Jessica A. Pollard, Michael R. Loken, Betsy Hirsch, Susana C. Raimondi, Janet Franklin, Stanley Pounds, Xueyuan Cao, Jeffrey E. Rubnitz, Raul C. Ribeiro, Alan S. Gamis, Soheil Meshinchi, Jatinder K. Lamba	42
19	Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment 2011 ·Journal of Clinical Oncology ·Roland B. Walter, Megan Othus, Gautam Borthakur, Farhad Ravandi, Jörge E. Cortes, Sherry Pierce, Frederick R. Appelbaum, Hagop Kantarjian, Elihu H. Estey	244
20	No influence of C-peptide, insulin, and glucagon on blood viscosity in vitro in healthy humans and patients with diabetes mellitus. 2001 ·PubMed ·(unknown), Roland B. Walter, (unknown), (unknown), Walter H. Reinhart	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact